(Z)-TETRAETHYL-[TETRAZOLO-[1,5-B]-PYRIDAZIN-6(5H)-YLIDENEAMINO]-METHYLENEDIPHOSPHONATE
Compound with spectra: 2 NMR
![(Z)-TETRAETHYL-[TETRAZOLO-[1,5-B]-PYRIDAZIN-6(5H)-YLIDENEAMINO]-METHYLENEDIPHOSPHONATE](/api/compound/43Wf0LqKSKI.png?ph=true&h=300&w=458 "(Z)-TETRAETHYL-[TETRAZOLO-[1,5-B]-PYRIDAZIN-6(5H)-YLIDENEAMINO]-METHYLENEDIPHOSPHONATE")
| SpectraBase Compound ID | 43Wf0LqKSKI |
|---|---|
| InChI | InChI=1S/C13H24N6O6P2/c1-5-22-26(20,23-6-2)13(27(21,24-7-3)25-8-4)14-11-9-10-12-15-17-18-19(12)16-11/h9-10,13H,5-8H2,1-4H3,(H,14,16) |
| InChIKey | BLQFKKRHWKCSAE-UHFFFAOYSA-N |
| Mol Weight | 422.32 g/mol |
| Molecular Formula | C13H24N6O6P2 |
| Exact Mass | 422.123257 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(Benzotriazol-1-ylmethyl)(tetrazolo[1,5-b]pyridazin-6-yl)amine
2-N,4-N-ditert-butyl-6-[4-(tetrazolo[1,5-b]pyridazin-6-yl)piperazin-1-yl]-1,3,5-triazine-2,4-diamine
TETRAETHYL-(BENZO-[D]-THIAZOL-2-YLAMINO)-METHYLENE-BIS-PHOSPHONATE
[1,2,4]triazolo[4,3-b]pyridazine, 6-[4-(2,4-dimethylphenyl)-1-piperazinyl]-
(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-[(E)-piperonylideneamino]amine
[1,2,4]triazolo[4,3-b]pyridazine, 3-methyl-6-[4-(2-pyridinyl)-1-piperazinyl]-
(4-Fluoro-phenyl)-(3,4,6-trichloro-5-trifluoromethyl-pyridin-2-yl)-amine
2-({(E)-2-cyano-2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]ethenyl}amino)benzamide
4,8-Diethylbenzo[1,2-d;4,5-d']bis[1,2,3]trithiole 2-oxide
(5E)-5-[4-(diethylamino)benzylidene]-2-[4-(3-methylphenyl)-1-piperazinyl]-1,3-thiazol-4(5H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and quantitative structure–activity relationship study of substituted imidazophosphor ester based tetrazolo[1,5-b]pyridazines as antinociceptive/anti-inflammatory agents | Beilstein Journal of Organic Chemistry | 2013 |